Möller, Lukas http://orcid.org/0000-0002-4375-8837
Aird, Eric J. http://orcid.org/0000-0002-4873-042X
Schröder, Markus S. http://orcid.org/0000-0001-5942-1254
Kobel, Lena http://orcid.org/0000-0001-7949-141X
Kissling, Lucas
van de Venn, Lilly http://orcid.org/0000-0003-0158-1225
Corn, Jacob E. http://orcid.org/0000-0002-7798-5309
Article History
Received: 14 June 2022
Accepted: 11 July 2022
First Online: 5 August 2022
Competing interests
: The REtarget code base is available for license through ETH. JEC is a cofounder and board member of Spotlight Therapeutics, an SAB member of Mission Therapeutics, an SAB member of Relation Therapeutics, an SAB member of Hornet Bio, an SAB member for the Joint AstraZeneca-CRUK Functional Genomics Centre, and a consultant for Cimeo Therapeutics. The lab of JEC has funded collaborations with Allogene. All other authors declare no competing interests.